Genomic Valley Biotech board to consider un-audited financial results

29 Oct 2015 Evaluate

Genomic Valley Biotech has informed that a meeting of the Board of Directors of the Company is scheduled on held on November 09, 2015, to consider and approve the Un-Audited Financial Results of the Company for the Second Quarter ended on September 30, 2015. Further, as per GVBL code of conduct for Prohibition of Insider Trading formulated, basis of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and as per the provisions of section 195 of the companies Act, 2013, The Trading window of the company shall remain closed for trading in the company equity shares from November 02, 2015 to November 10, 2015. As per the subject code for such of designated employees that can be reasonably expected to have possession of UPSI, the trading restriction applied to them from an earlier date and they had been intimated, not to trade in the equity shares of the Company till November 10, 2015.

The above information is a part of company’s filings submitted to BSE.

Genomic Valley Share Price

98.35 -2.00 (-1.99%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1690.60
Mangalam Global Ent 21.62
Kaveri Seed 822.10
Harrisons Malayalam 254.00
Simran Farms 206.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.